Automated rhythm-based control of radiofrequency ablation close to the atrioventricular node: Preclinical, animal, and first-in-human testing.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
05 2021
Historique:
received: 06 08 2020
revised: 03 10 2020
accepted: 14 10 2020
pubmed: 23 10 2020
medline: 19 1 2022
entrez: 22 10 2020
Statut: ppublish

Résumé

The risk of heart block during radiofrequency ablation of atrioventricular (AV) nodal reentrant tachycardia and septal accessory pathways is minimized by rapidly ceasing ablation in response to markers of risk, such as atrioventricular dissociation, fast junctional rhythm, PR interval prolongation, or 2 consecutive atrial or ventricular depolarizations. Currently this is done manually. The objectives of this study were to build and test a control system able to monitor cardiac rhythm and automatically terminate ablation energy when required. The device was built from off-shelf componentry. Preclinical testing involved real-time input of electrogram/electrocardiogram data from 209 ablation procedures (20 patients) over slow (n = 19) and fast (n = 1) AV nodal pathways. The device response speed was compared with the human response speed. The device's ability to prevent heart block was tested in 5 sheep. First-in-human testing was then performed in 12 patients undergoing AV nodal reentrant tachycardia ablation. Risk conditions necessitating shutoff of ablation (200 total; 111 preclinical and 89 first-in-human) were detected by the device with 100% sensitivity and 94% specificity, automatically terminating ablation while still allowing successful ablation in all patients. Device shutoff of ablation was always faster than human response (median difference 1.24 seconds). In each of 5 sheep, 40 consecutive attempts to cause heart block by ablating over the His bundle were unsuccessful because of automatic shutoff in response to rhythm change. Automated shutoff of ablation close to the AV node in response to markers of the risk of heart block is feasible with high accuracy as well as faster response than human response. The system may improve the safety of ablation near the AV node by preventing heart block.

Sections du résumé

BACKGROUND
The risk of heart block during radiofrequency ablation of atrioventricular (AV) nodal reentrant tachycardia and septal accessory pathways is minimized by rapidly ceasing ablation in response to markers of risk, such as atrioventricular dissociation, fast junctional rhythm, PR interval prolongation, or 2 consecutive atrial or ventricular depolarizations. Currently this is done manually.
OBJECTIVES
The objectives of this study were to build and test a control system able to monitor cardiac rhythm and automatically terminate ablation energy when required.
METHODS
The device was built from off-shelf componentry. Preclinical testing involved real-time input of electrogram/electrocardiogram data from 209 ablation procedures (20 patients) over slow (n = 19) and fast (n = 1) AV nodal pathways. The device response speed was compared with the human response speed. The device's ability to prevent heart block was tested in 5 sheep. First-in-human testing was then performed in 12 patients undergoing AV nodal reentrant tachycardia ablation.
RESULTS
Risk conditions necessitating shutoff of ablation (200 total; 111 preclinical and 89 first-in-human) were detected by the device with 100% sensitivity and 94% specificity, automatically terminating ablation while still allowing successful ablation in all patients. Device shutoff of ablation was always faster than human response (median difference 1.24 seconds). In each of 5 sheep, 40 consecutive attempts to cause heart block by ablating over the His bundle were unsuccessful because of automatic shutoff in response to rhythm change.
CONCLUSION
Automated shutoff of ablation close to the AV node in response to markers of the risk of heart block is feasible with high accuracy as well as faster response than human response. The system may improve the safety of ablation near the AV node by preventing heart block.

Identifiants

pubmed: 33091601
pii: S1547-5271(20)30977-2
doi: 10.1016/j.hrthm.2020.10.014
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

734-742

Informations de copyright

Copyright © 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Darren A Hooks (DA)

School of Medicine, University of Otago, Wellington, New Zealand; L'Institut de RYthmologie et Modélisation Cardiaque (LIRYC), Pessac, Bordeaux, France; Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France. Electronic address: darren.hooks@ccdhb.org.nz.

Remi Dubois (R)

L'Institut de RYthmologie et Modélisation Cardiaque (LIRYC), Pessac, Bordeaux, France.

Valentine Meillet (V)

L'Institut de RYthmologie et Modélisation Cardiaque (LIRYC), Pessac, Bordeaux, France.

John Nicot (J)

L'Institut de RYthmologie et Modélisation Cardiaque (LIRYC), Pessac, Bordeaux, France.

Benjamin Berte (B)

Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Seigo Yamashita (S)

Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Saagar Mahida (S)

Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Jean-Marc Sellal (JM)

Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Antonio Frontera (A)

Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Arnaud Denis (A)

Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Frederic Sacher (F)

L'Institut de RYthmologie et Modélisation Cardiaque (LIRYC), Pessac, Bordeaux, France; Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Nicolas Derval (N)

Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Ian Crozier (I)

Cardiology Department, Canterbury District Health Board, Christchurch, New Zealand.

Iain Melton (I)

Cardiology Department, Canterbury District Health Board, Christchurch, New Zealand.

Michel Haissaguerre (M)

L'Institut de RYthmologie et Modélisation Cardiaque (LIRYC), Pessac, Bordeaux, France; Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Pierre Jais (P)

L'Institut de RYthmologie et Modélisation Cardiaque (LIRYC), Pessac, Bordeaux, France; Cardiology Department, Hôpital Haut-Lévèque, Pessac, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH